This article originally appeared on The Gateway Pundit and was republished with permission.

Guest post by Jim Hᴏft

In December 2021, the FDA warned Americans not to use Ivermectin, which “is intended for animals” to treat or prevent COVID-19.

“Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dangerous,” FDA said at the time.

This was a very controversial statement at the time since the FDA pushed the drug on African migrants back in 2015, and the drug was praised in several scientific journals.

There have now been 101 Ivermectin COVID-19 controlled studies that show a 62% lower risk in early treatment in COVID-19 patients.

A group of brave doctors had filed a federal lawsuit against the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) over the agencies’ unlawful attempts to block the use of ivermectin in treating COVID-19.

The lawsuit, filed in the U.S. Southern District of Texas in Galveston, argues that the FDA has overstepped its authority and unjustifiably interfered with their medical practice.

The plaintiffs, Drs. Mary Talley Bowden, Paul E. Marik, and Robert L. Apter, are contesting the FDA’s portrayal of ivermectin as dangerous for human consumption. They note that the FDA has approved ivermectin for human use since 1996 for a variety of diseases. However, they allege that with the advent of the COVID-19 pandemic, the FDA began releasing documents and social media posts discouraging the use of the anti-viral drug for COVID-19 treatment.

“We’re suing the FDA for lying to the public about ivermectin,” said Dr. Bowden.

Claims were made that the initial article misrepresented the law by stating the FDA’s official stance against Ivermectin use without mentioning that doctors were allowed to administer the medicine.

U.S. law is cited in the complaint, including the provision that the FDA “may not interfere with the authority of a health care provider to prescribe or administer any legally marked device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship.”

On Thursday, the U.S. Food and Drug Administration (FDA) reportedly agreed to remove all its previous social media posts and consumer advisories that specifically addressed the use of ivermectin for the treatment or prevention of COVID-19.

“FDA loses its war on ivermectin and agrees to remove all social media posts and consumer directives regarding ivermectin and COVID, including its most popular tweet in FDA history. This landmark case sets an important precedent in limiting FDA overreach into the doctor-patient relationship,” Dr. Bowden wrote on her social media.

The plaintiffs have recently received the signed court order and are preparing to issue a press release about it later today.

Continue Reading